Wu, D., Boyd, A., & Wood, K. (2008). Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack.
Cita Chicago (17th ed.)Wu, D., A. Boyd, i K. Wood. Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack. 2008.
Cita MLA (9th ed.)Wu, D., et al. Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack. 2008.
Atenció: Aquestes cites poden no estar 100% correctes.